Hospital Acquired Disease Testing Market will Likely to Expand at a Steady CAGR of 19.9% by 2023


Posted May 15, 2019 by pragya11

Hospital Acquired Disease Testing Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023

 
Global Hospital Acquired Disease Testing Market Insights 

The rising incidence of hospital acquired infections (HAIs) has emerged as a major concern for governments, particularly across developing and underdeveloped countries. In first world countries such as the U.S., various regulations are in place for penalizing hospitals exhibiting a high incidence of HAIs. Such regulations augur well for the hospital acquired disease testing market in developed countries. In contrast, the absence of proper regulations and stringent policies limiting the adoption of molecular-biology-based diagnostics are restricting the expansion of the market across emerging nations.

Obtain Report Details @

https://www.transparencymarketresearch.com/hospital-acquired-disease-testing.html

Nevertheless, Transparency Market Research (TMR) forecasts the market to gain considerable momentum in the forthcoming years with the advent of the latest technologies. As per TMR, the global hospital acquired disease testing market stood at US$416.7 mn in 2014. Exhibiting a CAGR of 19.9% CAGR between 2015 and 2023, the market is expected to reach US$2.07 bn by the end of 2023.

Increasing Incidence of Urinary Tract Infections Fuels Demand for Hospital Acquired Disease Testing

Urinary tract infection is one of the most common hospital acquired infections affecting millions around the world. It has therefore emerged as the largest segment in the global hospital acquired disease testing market, based on test type. As per TMR, the segment was valued at US$155.3 mn in 2014. Rising at a CAGR of 19.8%, the urinary tract infection testing segment is forecast to reach 768.8 mn in 2023.

Request for Sample Copy of Report @

https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1759

Apart from this, the demand for hospital acquired disease testing will also rise in response to the increasing incidence of surgical site infection, pneumonia, and MRSA, which is considered the fastest growing HAI in the world. Hospital acquired disease testing is also used for the bloodstream test.

Request Report Brochure @

https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1759

About Us

Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Contact Us

Transparency Market Research
State Tower,
90 State Street, Suite 700
Albany, NY 12207
United States
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: [email protected]
Website: www.transparencymarketresearch.com
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By Pragya
Business Address State Tower,90 State Street, Suite 700
Country United States
Categories Health
Tags hospital acquired disease testing market
Last Updated May 15, 2019